Revenue
attach_money451M USD
YoY +146.7%
TARSTarsus Pharmaceuticals, Inc.$ --
Tarsus Pharmaceuticals, Inc.
TARS
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-71M USD
YoY +41.1%
Net Income
verified-66M USD
YoY +42.5%
EPS
pie_chart-1.59USD
YoY +48.2%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress25.7%On Track
Revenue Progress162.1M
Revenue Forecast689.4M
Net Income Progress-7M
Net Income Forecast-27.1M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.